Yes, it would have similar results. It seems that some of these combo drugs have shorter patents (and will have a generic equivalent sooner), so in the first 3 years it would still be cheaper to complain to the prescriber about cost and have them prescribed separately. There are slight differences in the release, for example, in the Namzaric example I gave, both ingredients are extended release (as opposed to immediate).
I know 'kickbacks' are in theory illegal but there is some kind of soft money / incentives happening. Pharmaceutical sales reps and medical science liaisons keep track of what their doctors prescribe.
Comments
Yes, it would have similar results. It seems that some of these combo drugs have shorter patents (and will have a generic equivalent sooner), so in the first 3 years it would still be cheaper to complain to the prescriber about cost and have them prescribed separately. There are slight differences in the release, for example, in the Namzaric example I gave, both ingredients are extended release (as opposed to immediate).
I know 'kickbacks' are in theory illegal but there is some kind of soft money / incentives happening. Pharmaceutical sales reps and medical science liaisons keep track of what their doctors prescribe.